Shinji Kuroda

16PUBLICATIONS
20CO-AUTHORS
Molecular targetsNutritional epidemiologyCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersEpidemiological methods
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Apr 27, 2026
Multi-Transcriptomic Analysis Reveals That EREG-Driven TME Crosstalk Defines Anti-EGFR Response in Colorectal Cancer.

|Mar 09, 2026
Risk Factors for Anastomotic Stricture and Obstructive Symptoms Following Double-Flap Technique Reconstruction After Proximal Gastrectomy.

Shinji Kuroda, Yoshihiko Kakiuchi, Satoru Kikuchi

|Feb 21, 2026
Turning pancreatic cancer from cold to hot: the promise of a p53-expressing oncolytic adenovirus (OBP-702).

Shinji Kuroda, Hiroshi Tazawa, Masashi Hashimoto

|Dec 18, 2025
Gut microbial metabolite butyrate boosts p53-expressing telomerase-specific oncolytic adenovirus efficacy by enhancing infectivity and activating MHC-I/cGAS-STING.

Masaki Sakamoto, Shinji Kuroda, Tetsuya Katayama

|Nov 04, 2025
Serum extracellular vesicles containing adenoviral E1A-DNA as a predictive biomarker for liquid biopsy in oncolytic adenovirus therapy.

Chiaki Yagi, Shinji Kuroda, Yoshihiko Kakiuchi

|Sep 24, 2025
Gemcitabine-induced neutrophil extracellular traps via interleukin-8-CXCR1/2 pathway promote chemoresistance in pancreatic cancer.

Shohei Nogi, Shunsuke Kagawa, Atsuki Taniguchi

Pageof 3

Frequent Collaborators

9 joint publications

Shunsuke Kagawa

6 joint publications

Hiroshi Tazawa

4 joint publications

Toshiyoshi Fujiwara

3 joint publications

Satoru Kikuchi